Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2002 Jan 8;16(1):37–39. doi: 10.1002/jcla.2056

Biological variability of thyroid autoantibodies (anti‐TPO and anti‐Tg) in clinically and biochemically stable patients with autoimmune thyroid disease

Concepción González 1,2, Monserrat Hernando 1, Fernando Cava 3, Eva Herrero 1, Luis Carlos García‐Díez 4, José Alejandro Navajo 1, José Manuel González‐Buitrago 1,2,
PMCID: PMC6807821  PMID: 11835529

Abstract

The biological variation of anti‐TPO and anti‐Tg autoantibodies was studied in 17 clinically and biochemically stable female patients with autoimmune thyroid disease (AITD), at regular monthly intervals over a period of 6 consecutive months. The mean and standard deviation (SD), within‐subject coefficient of variation (CV), between‐subject CV, index of individuality, reliability coefficient, and critical differences were as follows: for anti‐TPO 238 (197) U/ml, 9.2%, 81.4%, 0.11, 0.96, and 27.6%; and for anti‐Tg 1,785 (3,170) U/ml, 6.9%, 174%, 0.04, 0.99, and 22.3%. The data indicate a low within‐subject CV, and a high between‐subject CV that is particularly pronounced for anti‐Tg. The high individuality of both autoantibodies indicates that an isolated result compared to conventional population‐based reference intervals is of very little value for diagnosis. Furthermore, the near to 1 reliability coefficient for both autoantibodies correctly classifies the patient with respect to his or her homeostatic mean antibody concentration in a 6‐month period of clinical and biochemical stability of thyroid disease. Imprecision goals for anti‐TPO and anti‐Tg antibodies are attainable with current methodology. J. Clin. Lab. Anal. 16:37–39, 2002. © 2002 Wiley‐Liss, Inc.

Keywords: anti‐Tg antibodies, anti‐TPO antibodies, autoimmune thyroid disease, biological variability

REFERENCES

  • 1. Rapoport B, McLachlan SM. 1996. Thryroid peroxidase autoantibodies In: Peter JB, Shoenfeld Y, editors. Autoantibodies. Amsterdam: Elsevier Science; p 816–821. [Google Scholar]
  • 2. Burek CL, Rose NR. 1996. Thyroglobulin autoantibodies In: Peter JB, Shoenfeld Y, editors. Autoantibodies. Amsterdam: Elsevier Science; p 810–815. [Google Scholar]
  • 3. Fraser CG, Harris EK. 1989. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 27:409–437. [DOI] [PubMed] [Google Scholar]
  • 4. Harris EK. 1979. Statistical principles underlying analytic goal‐setting in clinical chemistry. Am J Clin Pathol 72:374–382. [PubMed] [Google Scholar]
  • 5. Harris EK, Boyd JC. 1995. Statistical bases of reference values in laboratory medicine. New York: Marcel Dekker. [Google Scholar]
  • 6. Stockl D, Baadenhuisjen H, Fraser CG, et al. 1995. Desirable routine analytical goals for quantities assayed in serum. Eur J Clin Chem Clin Biochem 33:157–169. [PubMed] [Google Scholar]
  • 7. Feldt Rasmussen U. 1996. Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglubulin, and thyrotropin receptor. Clin Chem 42:160–163. [PubMed] [Google Scholar]
  • 8. Fraser CG, Hyltoft Petersen P, Lieber JC, Ricos C. 1997. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 34:8–12. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES